U.S. FDA approves Wegovy pill for weight loss

In recent years, Novo Nordisk’s injectable Wegovy and Lilly’s Zepbound have revolutionised obesity treatment globally

from Industry News, Company News, Manufacturing News, Service Sector | The Hindu https://ift.tt/b4OVyBp

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Market in the US, 2025